ATE508737T1 - Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung - Google Patents
Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzungInfo
- Publication number
- ATE508737T1 ATE508737T1 AT07824998T AT07824998T ATE508737T1 AT E508737 T1 ATE508737 T1 AT E508737T1 AT 07824998 T AT07824998 T AT 07824998T AT 07824998 T AT07824998 T AT 07824998T AT E508737 T1 ATE508737 T1 AT E508737T1
- Authority
- AT
- Austria
- Prior art keywords
- polymorph
- pharmaceutical composition
- composition containing
- containing clopidogrel
- clopidogrel hydrogensulfate
- Prior art date
Links
- 229950010477 clopidogrel hydrogen sulphate Drugs 0.000 title abstract 2
- FDEODCTUSIWGLK-UHFFFAOYSA-N hydrogen sulfate;hydron;methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)acetate Chemical compound OS(O)(=O)=O.C1CC=2SC=CC=2CN1C(C(=O)OC)C1=CC=CC=C1Cl FDEODCTUSIWGLK-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002775 capsule Substances 0.000 abstract 1
- FDEODCTUSIWGLK-RSAXXLAASA-N clopidogrel sulfate Chemical compound [H+].OS([O-])(=O)=O.C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl FDEODCTUSIWGLK-RSAXXLAASA-N 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0600839A HUP0600839A3 (en) | 2006-11-14 | 2006-11-14 | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
| PCT/HU2007/000106 WO2008059298A2 (en) | 2006-11-14 | 2007-11-13 | Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE508737T1 true ATE508737T1 (de) | 2011-05-15 |
Family
ID=89987134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07824998T ATE508737T1 (de) | 2006-11-14 | 2007-11-13 | Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2101742B8 (de) |
| AT (1) | ATE508737T1 (de) |
| EA (1) | EA015440B1 (de) |
| HU (1) | HUP0600839A3 (de) |
| WO (1) | WO2008059298A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721410B (zh) * | 2008-10-30 | 2012-01-25 | 南京正大天晴制药有限公司 | 硫酸氢氯吡格雷的固体药物组合物 |
| CN101766573B (zh) | 2010-02-05 | 2013-02-13 | 上海安必生制药技术有限公司 | 硫酸氢氯吡格雷固体制剂的制备工艺 |
| RU2540519C2 (ru) * | 2013-02-05 | 2015-02-10 | Общество с ограниченной ответственностью "Трейдсервис" | Лекарственная форма клопидогрела |
| CN105106165A (zh) * | 2015-08-19 | 2015-12-02 | 海南科进生物制药有限公司 | 一种硫酸氢氯吡咯雷片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2792836B3 (fr) * | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
| CA2363053C (en) * | 2001-11-09 | 2011-01-25 | Bernard Charles Sherman | Clopidogrel bisulfate tablet formulation |
| AU2002366383B2 (en) * | 2001-12-18 | 2007-06-14 | Teva Pharmaceutical Industries Ltd. | Polymorphs of clopidogrel hydrogensulfate |
| WO2005070464A2 (en) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A tablet formulation of clopidogrel bisulphate |
| EP1674468A1 (de) * | 2004-12-21 | 2006-06-28 | Ratiopharm GmbH | Polymorphe von Clopidogrel Hydrobromid |
-
2006
- 2006-11-14 HU HU0600839A patent/HUP0600839A3/hu unknown
-
2007
- 2007-11-13 AT AT07824998T patent/ATE508737T1/de not_active IP Right Cessation
- 2007-11-13 EA EA200900622A patent/EA015440B1/ru not_active IP Right Cessation
- 2007-11-13 WO PCT/HU2007/000106 patent/WO2008059298A2/en active Application Filing
- 2007-11-13 EP EP07824998A patent/EP2101742B8/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2101742B1 (de) | 2011-05-11 |
| EA200900622A1 (ru) | 2009-10-30 |
| HUP0600839A3 (en) | 2008-09-29 |
| WO2008059298A3 (en) | 2008-10-23 |
| EP2101742B8 (de) | 2011-09-21 |
| EA015440B1 (ru) | 2011-08-30 |
| WO2008059298A2 (en) | 2008-05-22 |
| HU0600839D0 (en) | 2007-01-29 |
| HUP0600839A2 (en) | 2008-07-28 |
| EP2101742A2 (de) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1126116T1 (el) | Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| EA201170772A1 (ru) | Органические соединения | |
| NO20085415L (no) | Farmasøytisk doseringsform inneholdende fenylefrin med vedvarende frigivelse | |
| EA201490477A1 (ru) | Фармацевтические составы, содержащие пропиленгликоль-гидрат дапаглифлозина | |
| EA200600320A1 (ru) | γ-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
| EA200600321A1 (ru) | βd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
| EA200601662A1 (ru) | δ-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
| EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
| EA200600322A1 (ru) | β-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
| MX2009005462A (es) | Analogos de 7,8-saturados-4,5-epoxi-morfinano. | |
| EA201000784A1 (ru) | Антагонисты пути hedgehog и их терапевтические применения | |
| BRPI0613664A8 (pt) | antagonista de 3-lactamil fenilalanina,cisteína e serina vasopressina | |
| EA201401193A1 (ru) | Триарильные соединения и композиции, их содержащие | |
| EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| NO20064783L (no) | Opplosningstabeletter med licarbazepin | |
| EA201200485A1 (ru) | Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол | |
| ATE508737T1 (de) | Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung | |
| IL191670A0 (en) | Compounds for the inhibition of apoptosis | |
| ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
| EA200701178A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| IL188848A (en) | A transient receptor antagonist (TRPVI) i, a pharmaceutical preparation containing it for the treatment of related diseases and conditions. | |
| ATE438381T1 (de) | Zolpidemtabletten | |
| GB0620619D0 (en) | Novel compounds | |
| EA201170843A1 (ru) | Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |